Pfizer/Pharmacia merger
This article was originally published in The Tan Sheet
Executive Summary
Firms reach deal with FTC on divestitures necessary to complete Pfizer's acquisition of Pharmacia, according to March 17 release. Companies further note "they have signed agreements...with buyers for all of the assets to be divested." Pfizer's Rx urinary incontinence drug darifenacin is being divested to Novartis due to Pharmacia's $750 mil. Detrol (tolterodine) franchise. Overlapping consumer brands that could face divestiture include Pharmacia's Dramamine, Pfizer's Bonine motion sickness tablets, which account for more than 70% of the market, and topical anti-itch remedies under Pharmacia's Cortaid, Pfizer's Benadryl, Caladryl, Cortizone lines (1"The Tan Sheet" Jan. 27, 2003, p. 5)...